John King - Concepedia

Author

John King

The Royal Melbourne Hospital

Also Known As

, Anneke Van der Walt, J King, J O King, J. KING, J. King, J. O. KING, J. O. King, J.O. King, JOHN KING

122

Publications

6.3K

Citations

H-Index

123

Concepts

All Affiliations

The Royal Melbourne Hospital The University of Melbourne University of Oxford Royal Children's Hospital The University of Sydney

About

John King is an author at The Royal Melbourne Hospital specializing in medicine, neuropathology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	2.6K
2	Education	4	4	700
3	Health Sciences	3	3	644
4	Business	2	2	55
5	Management	1	1	18

John King

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Randomized Trial of Thymectomy in Myasthenia Gravis Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, New England Journal of Medicine	2016	873
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial Vittorio Martinelli, M. Rodegher, Lucia Moiola, The Lancet Neurological DisorderMedicineClinical NeurologyClinical TrialsPrecise Study	2009	585
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS G. Francis, Richard AC Hughes, John King, DIAL (Catholic University of Leuven)	2001	472
Fetal valproate syndrome and autism: additional evidence of an association Gail Williams, John King, Michael L. Cunningham, Developmental Medicine & Child Neurology Genetic EpidemiologyFetal MedicineEducationNeurodiversityFetal Valproate Syndrome	2001	363
Manometry combined with cervical puncture in idiopathic intracranial hypertension John King, Peter Mitchell, KR Thomson, Neurology	2002	282
Fetal valproate syndrome and autism: additional evidence of an association Gail Williams, John King, Michael L. Cunningham, Developmental Medicine & Child Neurology Genetic EpidemiologyFetal MedicineEducationNeurodiversityFetal Valproate Syndrome	2001	282
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring Ludwig Kappos, David O. Bates, Gilles Edan, The Lancet Neurology Translational MedicineSystemic SclerodermaMedicineImmunologyClinical Trials	2011	265
Cerebral venography and manometry in idiopathic intracranial hypertension John King, Peter Mitchell, KR Thomson, Neurology HypertensionTransverse SinusMedicineVascular MalformationVenous Hypertension	1995	248
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, The Lancet Neurology	2019	216
INHERITANCE OF MALIGNANT HYPERPYREXIA John King, M. A. Denborough, P.W. Zapf The Lancet UrologyMendelian DisorderGenetic DisorderInherited Metabolic DiseasePathology	1972	123

Page 1